CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in CRNX — Crinetics Pharmaceuticals, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in CRNX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$30,269,741
-$6,131,474 QoQ
Shares Held
833,418
+6.6% QoQ
Ownership
0.790%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,184,692,793 across 287 Biotechnology names. CRNX ranks #44 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in CRNX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $30,269,741 | 833,418 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $36,401,215 | 781,981 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $32,430,855 | 778,652 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $22,036,717 | 766,228 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $25,273,295 | 753,527 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $38,814,112 | 759,126 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $33,491,859 | 655,418 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $26,741,824 | 597,049 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $22,400,082 | 478,532 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $16,735,871 | 470,373 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $13,719,151 | 461,303 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $6,320,298 | 350,738 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $5,549,806 | 345,567 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $6,277,906 | 343,055 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,602,771 | 336,190 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,185,664 | 331,671 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $6,543,843 | 298,125 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $8,231,371 | 289,735 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $4,699,349 | 223,247 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $3,693,110 | 195,921 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,303,490 | 150,752 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,126,701 | 150,723 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,301,468 | 146,871 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,364,744 | 134,974 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $775,013 | 52,722 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||